Kimialys
3 known investors
Kimialys provides antibody selection and kinetic characterization services using proprietary Surface Plasmon Resonance imaging (SPRi) technology and K-One surface chemistry for researchers and diagnostics developers. The platform enables rapid identification of optimal antibody candidates for diagnostic assays and therapeutic development across multiple assay formats.
Investors · 3
Frequently asked questions
- What does Kimialys do?
- Kimialys provides antibody selection and kinetic characterization services using proprietary Surface Plasmon Resonance imaging (SPRi) technology and K-One surface chemistry for researchers and diagnostics developers. The platform enables rapid identification of optimal antibody candidates for diagnostic assays and therapeutic development across multiple assay formats.
- Who are Kimialys's investors?
- Kimialys's investors include Angels Santé, Octalfa, Super Capital VC.